ACT DILTIAZEM T
ACTAVIS PHARMA COMPANY
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ACT DILTIAZEM T discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ACT DILTIAZEM T 360MG has been permanently discontinued (last updated May 14, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ACT DILTIAZEM T not available?
The reason the manufacturer reported: Business reasons.
Diltiazem CD Shortage in Canada: Which Brands Are Affected
Which diltiazem CD capsules (Apo-Diltiaz CD, Jamp, Pro-Diltiazem CD, Sanis) are in shortage in Canada right now, why CD, SR, and XC versions aren't interchangeable, and what your pharmacist can switch you to.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
ALTI-DILTIAZEM TAB 60MG
ALTIMED PHARMA INC.
NU-DILTIAZ TAB 60MG
NU-PHARM INC
CARDIZEM SR 90MG
Extended-ReleaseBIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION
CARDIZEM SR 60MG
Extended-ReleaseBIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION
DILTIAZEM-60 TAB 60MG
PRO DOC LIMITEE
CARDIZEM SR 120MG
Extended-ReleaseBIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02370522
Strength
360MG
Dosage Form
CAPSULE (EXTENDED RELEASE)
Route
ORAL
Compare with another product →
Shortage History
Other Products from ACTAVIS PHARMA COMPANY
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
4MG · DIN 02376520
DIN 02388650
5MG · DIN 02354462
100MG · DIN 02256142
38MG · DIN 02433117
DIN 02357402
DIN 02357410
DIN 02357399
20MG · DIN 02271478
5MG · DIN 02271443
10MG · DIN 02271451
25MG · DIN 02354829